Coronavirus disease 2019 in pregnancy: early lessons.
Acute Kidney Injury
/ etiology
Adult
Anesthesia, General
Anti-Bacterial Agents
/ therapeutic use
Antihypertensive Agents
/ therapeutic use
Azithromycin
/ therapeutic use
Bronchial Spasm
/ therapy
COVID-19
/ complications
Carrier State
Ceftriaxone
/ therapeutic use
Cesarean Section
Diabetes Mellitus, Type 2
/ complications
Enzyme Inhibitors
/ therapeutic use
Female
Fever
/ physiopathology
Health Personnel
Hospitalization
Humans
Hydroxychloroquine
/ therapeutic use
Hypertension
/ complications
Intensive Care Units
Intubation, Intratracheal
Labor, Induced
New York City
Nicardipine
/ therapeutic use
Occupational Exposure
Oxygen Inhalation Therapy
Postpartum Hemorrhage
/ therapy
Pregnancy
Pregnancy Complications, Cardiovascular
/ drug therapy
Pregnancy Complications, Infectious
/ diagnosis
Pregnancy in Diabetics
Respiration, Artificial
SARS-CoV-2
Uterine Inertia
/ therapy
COVID-19
novel coronavirus
pregnancy
Journal
American journal of obstetrics & gynecology MFM
ISSN: 2589-9333
Titre abrégé: Am J Obstet Gynecol MFM
Pays: United States
ID NLM: 101746609
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
entrez:
11
6
2020
pubmed:
11
6
2020
medline:
11
6
2020
Statut:
ppublish
Résumé
The worldwide incidence of coronavirus disease 2019 (COVID-19) infection is rapidly increasing, but there exists limited information on coronavirus disease 2019 in pregnancy. Here, we present our experience with 7 confirmed cases of coronavirus disease 2019 in pregnancy presenting to a single large New York City tertiary care hospital. Of the 7 patients, 5 presented with symptoms of coronavirus disease 2019, including cough, myalgias, fevers, chest pain, and headache. Of the 7 patients, 4 were admitted to the hospital, including 2 who required supportive care with intravenous hydration. Of note, the other 2 admitted patients who were asymptomatic on admission to the hospital, presenting instead for obstetrically indicated labor inductions, became symptomatic after delivery, each requiring intensive care unit admission.
Identifiants
pubmed: 32518902
doi: 10.1016/j.ajogmf.2020.100111
pii: S2589-9333(20)30041-0
pii: 100111
pmc: PMC7271091
doi:
Substances chimiques
Anti-Bacterial Agents
0
Antihypertensive Agents
0
Enzyme Inhibitors
0
Hydroxychloroquine
4QWG6N8QKH
Ceftriaxone
75J73V1629
Azithromycin
83905-01-5
Nicardipine
CZ5312222S
Types de publication
Case Reports
Journal Article
Langues
eng
Pagination
100111Informations de copyright
© 2020 Elsevier Inc. All rights reserved.
Références
Am J Obstet Gynecol MFM. 2020 May;2(2):100109
pubmed: 32309798
Lancet. 2020 Mar 7;395(10226):809-815
pubmed: 32151335
JAMA. 2020 Apr 14;323(14):1406-1407
pubmed: 32083643
J Infect Dis. 2020 May 11;221(11):1770-1774
pubmed: 32179910
Am J Obstet Gynecol MFM. 2020 May;2(2):100107
pubmed: 32292902